Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL790241 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL11441097 | 0.94 | — | — | |
| SCHEMBL1314338 | 0.92 | — | — | |
| SCHEMBL20922138 | 0.90 | CA12 (0.65) | — | |
| SCHEMBL7246326 | 0.89 | ADH1B (0.56) | — | |
| SCHEMBL6985845 | 0.89 | ADH1B (0.56) | — | |
| SCHEMBL2744454 | 0.89 | — | — | |
| SCHEMBL5255853 | 0.89 | ADH1B (0.56) | — | |
| SCHEMBL9556470 | 0.89 | ADH1B (0.56) | — | |
| SCHEMBL7238378 | 0.89 | ADH1B (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102325550-A | Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature | QUADRA LOGIC TECH INC | 2012-01-18 | — | — | CN | disclosed |
| CN-1874789-A | Conjugates for photodynamic therapy | LIGHT SCIENCES CORP (US) | 2006-12-06 | — | — | CN | disclosed |